Literature DB >> 7821176

Prevalence of adult-onset IDDM in the U.S. population.

M I Harris1, D C Robbins.   

Abstract

OBJECTIVE: To investigate the prevalence of adult-onset insulin-dependent diabetes mellitus (IDDM) in a nationally representative sample of adults 30-74 years of age. Although it is a widely held belief that onset of IDDM in adults is rare, there are few objective data to support this. Adult-onset IDDM may represent a disease that is biologically distinct from youth-onset IDDM, and it would be important to distinguish these two entities. RESEARCH DESIGN AND METHODS: The Second National Health and Nutrition Examination Survey (NHANES II) contained a national probability sample of 12,102 subjects 30-74 years of age in the U.S. population. All subjects with diabetes diagnosed by a physician before the survey were identified. Cases of IDDM defined by age at diagnosis > or = 30 years, continuous or nearly continuous insulin treatment since diagnosis of diabetes, and relative body weight < or = 125 were classified as adult-onset IDDM.
RESULTS: Subjects with adult-onset IDDM represented 0.30% of the U.S. population 30-74 years of age and 7.4% of all diabetic patients diagnosed at 30-74 years of age.
CONCLUSIONS: These data indicate that onset of IDDM in adults is uncommon. Given the limitations of the survey instrument, subclinical or slowly progressive IDDM (as distinguished from non-insulin-dependent diabetes mellitus with progressive loss of beta-cell function) would not have been detected, and these would constitute additional cases of adult-onset IDDM. However, the data suggest that a very large population base would be required to identify sufficient numbers of adult-onset IDDM cases for study of the etiology and pathogenesis of this disease.

Entities:  

Mesh:

Year:  1994        PMID: 7821176     DOI: 10.2337/diacare.17.11.1337

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Education, income, occupation, and the 34-year incidence (1965-99) of Type 2 diabetes in the Alameda County Study.

Authors:  Siobhan C Maty; Susan A Everson-Rose; Mary N Haan; Trivellore E Raghunathan; George A Kaplan
Journal:  Int J Epidemiol       Date:  2005-08-24       Impact factor: 7.196

2.  Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population.

Authors:  A Gürlek; T Erbaş; S Sayinalp; O Gedik
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

3.  Gene therapy in diabetes.

Authors:  Mary S Wong; Wayne J Hawthorne; Nicholas Manolios
Journal:  Self Nonself       Date:  2010-06-09

4.  Diabetes and its impact on health-related quality of life: a life table analysis.

Authors:  Khokan C Sikdar; Peizhong Peter Wang; Don MacDonald; Veerabhadra G Gadag
Journal:  Qual Life Res       Date:  2010-03-27       Impact factor: 4.147

5.  An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies.

Authors:  J LaGasse; L Jelinek; S Sexson; C Lofton-Day; J Breininger; P Sheppard; W Kindsvogel; W A Hagopian
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

Review 6.  Molecular targeting of pancreatic disorders.

Authors:  Kiichi Tamada; Xiao-Ping Wang; F Charles Brunicardi
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

7.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

8.  Childhood socioeconomic position, gender, adult body mass index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda County Study.

Authors:  Siobhan C Maty; John W Lynch; Trivellore E Raghunathan; George A Kaplan
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

9.  Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey.

Authors:  Richard L Nahin; Danita Byrd-Clark; Barbara J Stussman; Nilesh Kalyanaraman
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

10.  Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats.

Authors:  Ashish Kumar Sharma; Akash Sharma; Rita Kumari; Kunal Kishore; Divya Sharma; Bharthu Parthsarthi Srinivasan; Ashok Sharma; Santosh Kumar Singh; Samir Gaur; Vijay Singh Jatav; Prashant Sharma; Varnika Srivastava; Sneha Joshi; Megha Joshi; Prashant Kumar Dhakad; Davender Singh Kanawat; Akanksha Mishra; Anil Sharma; Dharmendra Singh; Ravinder Pal Singh; Himmat Singh Chawda; Rambir Singh; Sachin Kumar Raikwar; Muneem Kumar Kurmi; Pankaj Khatri; Ashutosh Agarwal; Arshee Munajjam
Journal:  J Biomed Res       Date:  2012-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.